MedPath

Effect of Gastric Bypass Surgery on Pancreatic Islet and Incretin Function - Follow-up Study

Completed
Conditions
Obesity
Registration Number
NCT02161666
Lead Sponsor
Hvidovre University Hospital
Brief Summary

To examine pancreatic islet function and incretin function during intravenous and oral stimulation \>2 years after gastric bypass surgery in patients with normal glucose tolerance. We hypothesize that islet cell and incretin function is enhanced in response to oral, but not intravenous, stimulation - i.e. incretin released from the gut in response to oral stimulation play a key role for the enhanced islet function after gastric bypass surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • Participation in previous study (NCT01559779)
Exclusion Criteria
  • Pregnancy/lactation
  • Major chronic disease develop since previous examination with possible impact on outcomes

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in islet cell function from baseline (preoperatively)>24 months

Change in insulin and glucagon secretion during oral and intravenous stimulation after gastric bypass

Secondary Outcome Measures
NameTimeMethod
Change in glucose tolerance during oral glucose tolerance test>24 months

Fasting, peak and nadir glucose during oral glucose tolerance test

Arterio-venous glucose difference during oral glucose tolerance test after gastric bypass>24 months

Differences in arterial and venous plasma glucose during oral glucose stimulation

Trial Locations

Locations (1)

Hvidovre University Hospital

🇩🇰

Hvidovre, Danmark, Denmark

© Copyright 2025. All Rights Reserved by MedPath